Polydex Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Polydex Pharmaceuticals has a total shareholder equity of $4.8M and total debt of $134.2K, which brings its debt-to-equity ratio to 2.8%. Its total assets and total liabilities are $6.0M and $1.1M respectively.
Key information
2.8%
Debt to equity ratio
US$134.19k
Debt
| Interest coverage ratio | n/a |
| Cash | US$328.82k |
| Equity | US$4.85m |
| Total liabilities | US$1.15m |
| Total assets | US$5.99m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: POLX.F's short term assets ($2.8M) exceed its short term liabilities ($1.1M).
Long Term Liabilities: POLX.F's short term assets ($2.8M) exceed its long term liabilities ($82.2K).
Debt to Equity History and Analysis
Debt Level: POLX.F has more cash than its total debt.
Reducing Debt: POLX.F's debt to equity ratio has reduced from 12.3% to 2.8% over the past 5 years.
Debt Coverage: POLX.F's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if POLX.F's interest payments on its debt are well covered by EBIT.